Brief: Microba Life Sciences Says Q4 FY23 Unaudited Revenue Totalled A$2.25M
27/07/2023 02:31
July 27 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* Q4 FY23 UNAUDITED REVENUE TOTALLED A$2.25M, UP 21.5% YOY
Source text for Eikon: ID:nASX76Lgjq
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement